Get started
Author

Hrvoje Holik

Observed names: H. Holik, Holik Hrvoje, Holik, Hrvoje
ORCID: 0000-0002-3767-5779
Observed ORCID: 0000-0002-3767-5779
OpenAlex ID: A5085755441
Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis
2020 · Marko Lucijanic, Davor Galusic, et al. · Annals of Hematology · 35
Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera
2020 · Ivan Krečak, Hrvoje Holik, et al. · International Journal of Hematology · 29
Neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratios as prognostic biomarkers in polycythemia vera
2021 · Ivan Krečak, Hrvoje Holik, et al. · International Journal of Laboratory Hematology · 21
The impact of statins on the intensity of phlebotomies in polycythemia vera
2020 · Ivan Krečak, Hrvoje Holik, et al. · Annals of Hematology · 21
Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients
2021 · Ivan Krečak, Hrvoje Holik, et al. · Thrombosis Research · 20
The triple A model (age, absolute neutrophil count, absolute lymphocyte count‐ AAA ) predicts survival and thrombosis in polycythemia vera
2024 · Ivan Krecak, Danijela Lekovic, et al. · American Journal of Hematology · 18
PDF
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
2022 · Marko Lucijanic, Ivan Krecak, et al. · Leukemia Research · 18
High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia
2022 · Ivan Krečak, Hrvoje Holik, et al. · Wiener klinische Wochenschrift · 16
Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis
2021 · Marko Lucijanic, Ivan Krecak, et al. · Wiener klinische Wochenschrift · 16
Beneficial effect of ACE inhibitors on kidney function in polycythemia vera
2021 · Ivan Krečak, Martina Morić Perić, et al. · Wiener klinische Wochenschrift · 14
Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis
2023 · Marko Lucijanic, Ivan Krecak, et al. · Biochemia Medica · 12
PDF
Estimating plasma volume using the Strauss‐derived formula may improve prognostication in polycythemia vera
2021 · Ivan Krečak, Ivan Zekanović, et al. · International Journal of Laboratory Hematology · 12
No Impact of the Increased Number of Cardiovascular Risk Factors on Thrombosis and Survival in Polycythemia Vera
2021 · Ivan Krečak, Martina Morić Perić, et al. · Oncology Research and Treatment · 12
Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series
2023 · Livija Šimičević, Ana Marija Slišković, et al. · Pharmacy · 11
PDF
Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera
2021 · Ivan Krečak, Hrvoje Holik, et al. · Annals of Hematology · 11
Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis
2024 · Marko Lucijanic, Ivan Krecak, et al. · Life · 10
PDF
Circulating YKL-40 in Philadelphia-negative myeloproliferative neoplasms
2019 · Ivan Krečak, Velka Gverić-Krečak, et al. · Acta Clinica Belgica · 10
Higher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis
2021 · Marko Lucijanic, Ivan Krecak, et al. · Annals of Hematology · 9
C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis
2020 · Marko Lucijanic, Davor Galusic, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 9
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis
2024 · Marko Lucijanic, Ivan Krecak, et al. · Annals of Hematology · 8
Hip and Knee Osteoarthritis in Patients with Chronic Myeloproliferative Neoplasms: A Cross-Sectional Study
2023 · Hrvoje Holik, Ivan Krečak, et al. · Life · 8
PDF
Hematocrit to hemoglobin ratio as a prognostic marker in polycythemia vera
2021 · Ivan Krečak, Marko Lucijanić, et al. · Wiener klinische Wochenschrift · 8
Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications
2024 · Ivan Krecak, Danijela Lekovic, et al. · Journal of Clinical Medicine · 6
Chronic Kidney Disease has a Higher Prevalence in Polycythemia Vera than in Secondary Polycythemia, a Matched Case–Control Analysis
2022 · Ivan Krečak, Hrvoje Holik, et al. · Indian Journal of Hematology and Blood Transfusion · 6
PDF
Autoimmune disorders and the risk of thrombotic events in polycythaemia vera
2021 · Ivan Krečak, Hrvoje Holik, et al. · Leukemia Research · 5
Works count: 86
Citation count: 422
H-index: 12
I10-index: 17
Year
Topic
Type